Cargando…
The LAT1 inhibitor JPH203 reduces growth of thyroid carcinoma in a fully immunocompetent mouse model
BACKGROUND: The L-type amino acid transporter 1 (LAT1/SLC7A5) transports essential amino acids across the plasma membrane. While LAT1 is overexpressed in a variety of human neoplasms, its expression and its role in thyroid cancer is currently unknown. Anaplastic thyroid carcinoma (ATC) is a highly a...
Autores principales: | Häfliger, Pascal, Graff, Julien, Rubin, Matthias, Stooss, Amandine, Dettmer, Matthias S., Altmann, Karl-Heinz, Gertsch, Jürg, Charles, Roch-Philippe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6150977/ https://www.ncbi.nlm.nih.gov/pubmed/30241549 http://dx.doi.org/10.1186/s13046-018-0907-z |
Ejemplares similares
-
Insights into the Transport Cycle of LAT1 and Interaction with the Inhibitor JPH203
por: Brunocilla, Chiara, et al.
Publicado: (2023) -
Small molecule inhibitors provide insights into the relevance of LAT1 and LAT2 in materno‐foetal amino acid transport
por: Zaugg, Jonas, et al.
Publicado: (2020) -
LAT1 inhibitor JPH203 sensitizes cancer cells to radiation by enhancing radiation-induced cellular senescence
por: Bo, Tomoki, et al.
Publicado: (2021) -
Combined MEK and Pi3′-kinase inhibition reveals synergy in targeting thyroid cancer in vitro and in vivo
por: ElMokh, Oussama, et al.
Publicado: (2017) -
The Anti-Tumor Effect of the Newly Developed LAT1 Inhibitor JPH203 in Colorectal Carcinoma, According to a Comprehensive Analysis
por: Otani, Rina, et al.
Publicado: (2023)